Novartis Ag (NVS) FCF Margin (2009 - 2025)

Novartis Ag (NVS) has 15 years of FCF Margin data on file, last reported at 49.77% in Q2 2025.

• Quarterly FCF Margin rose 873.0% year-over-year to 49.77% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 20.87% (down 614.0% YoY) and the FY2025 annual result came in at 32.27%, down 3.0% from the prior year.
• FCF Margin improved to 49.77% in Q2 2025 per NVS's latest filing, from 31.63% in the prior quarter.
• The five-year high for FCF Margin was 2248.03% in Q4 2022, with the low at 26.5% in Q4 2021.
• Average FCF Margin over 5 years is 215.39%, with a median of 45.41% recorded in 2024.
• Year-over-year, FCF Margin sank 287020 bps in 2021 and soared 222153 bps in 2022.
• Novartis Ag's FCF Margin stood at 26.5% in 2021, then surged by 8383 bps to 2248.03% in 2022, then slumped by 99 bps to 31.21% in 2023, then gained by 1 bps to 31.63% in 2024, then soared by 57 bps to 49.77% in 2025.
• Business Quant data shows NVS's FCF Margin at 49.77% in Q2 2025, 31.63% in Q4 2024, and 41.04% in Q2 2024.